Dx Deals: Collaboration Takes Psoriasis Testing to New Level
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.
Release of second-generation Cologuard test data and recently announced partnerships aim to position company well for the future.
The national retailer recently signed a deal with Simple HealthKit to provide Walmart customers online access to at-home diagnostic test kits.
A recent report offers new insight into bankruptcy trends within the sector starting before the COVID-19 pandemic.
April was among the busiest months, in recent memory, in terms of both deal volume and significance in the diagnostics industry.
Product integration collaborations have become increasingly common, with five such deals being announced between February and mid-March.